187 related articles for article (PubMed ID: 20717915)
1. Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.
VanDevanter DR; Wagener JS; Pasta DJ; Elkin E; Jacobs JR; Morgan WJ; Konstan MW
Pediatr Pulmonol; 2010 Dec; 45(12):1156-66. PubMed ID: 20717915
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
[TBL] [Abstract][Full Text] [Related]
3. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.
Steinkamp G; Wiedemann B
Thorax; 2002 Jul; 57(7):596-601. PubMed ID: 12096202
[TBL] [Abstract][Full Text] [Related]
4. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality before age 18 years in cystic fibrosis.
McColley SA; Schechter MS; Morgan WJ; Pasta DJ; Craib ML; Konstan MW
Pediatr Pulmonol; 2017 Jul; 52(7):909-915. PubMed ID: 28436621
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
Konstan MW; Wagener JS; Pasta DJ; Millar SJ; Jacobs JR; Yegin A; Morgan WJ;
Pediatr Pulmonol; 2011 Jun; 46(6):545-53. PubMed ID: 21438174
[TBL] [Abstract][Full Text] [Related]
8. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
Ren CL; Konstan MW; Yegin A; Rasouliyan L; Trzaskoma B; Morgan WJ; Regelmann W;
J Cyst Fibros; 2012 Jul; 11(4):293-9. PubMed ID: 22445849
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility and predicted equations of spirometry in Shenzhen preschool children].
Zhang QL; Zheng JP; Yuan BT; He H; Wang J; An JY; Zhang M; Luo DF; Chen GL
Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):843-8. PubMed ID: 16316535
[TBL] [Abstract][Full Text] [Related]
10. The CF-ABLE score: a novel clinical prediction rule for prognosis in patients with cystic fibrosis.
McCarthy C; Dimitrov BD; Meurling IJ; Gunaratnam C; McElvaney NG
Chest; 2013 May; 143(5):1358-1364. PubMed ID: 23172242
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
12. Lung function decline from adolescence to young adulthood in cystic fibrosis.
Vandenbranden SL; McMullen A; Schechter MS; Pasta DJ; Michaelis RL; Konstan MW; Wagener JS; Morgan WJ; McColley SA;
Pediatr Pulmonol; 2012 Feb; 47(2):135-43. PubMed ID: 22241571
[TBL] [Abstract][Full Text] [Related]
13. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
[TBL] [Abstract][Full Text] [Related]
14. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
15. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
16. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
Sanders DB; Fink A; Mayer-Hamblett N; Schechter MS; Sawicki GS; Rosenfeld M; Flume PA; Morgan WJ
J Pediatr; 2015 Nov; 167(5):1081-8.e1. PubMed ID: 26340874
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary exacerbations in cystic fibrosis.
Rabin HR; Butler SM; Wohl ME; Geller DE; Colin AA; Schidlow DV; Johnson CA; Konstan MW; Regelmann WE;
Pediatr Pulmonol; 2004 May; 37(5):400-6. PubMed ID: 15095322
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.
Kinghorn B; McNamara S; Genatossio A; Sullivan E; Siegel M; Bauer I; Clem C; Johnson RC; Davis M; Griffiths A; Wheeler W; Johnson K; Davis SD; Leigh MW; Rosenfeld M; Pittman J
Ann Am Thorac Soc; 2020 Sep; 17(9):1085-1093. PubMed ID: 32603187
[No Abstract] [Full Text] [Related]
19. Early childhood wheezing is associated with lower lung function in cystic fibrosis.
Ren CL; Konstan MW; Rosenfeld M; Pasta DJ; Millar SJ; Morgan WJ;
Pediatr Pulmonol; 2014 Aug; 49(8):745-50. PubMed ID: 24123917
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
